Amarin Corp Plc (AMRN)

[Mellowmood77]

CADTH sure updates every 2 weeks. From CADTH:

As you’ve probably seen, you can follow the status of our review of Vescepa through CADTH’s Common Drug Review process using the status page: https://www.cadth.ca/icosapent-ethyl We update our status pages every two weeks.

This review is temporarily suspended, waiting for additional information from the company who makes Vascepa. CADTH’s Common Drug Reviews typically take 6 months. Following the funding recommendations made by CADTH, the pan-Canadian Pharmaceutical Alliance will negotiate price on behalf of the publicly funded drug plans. This takes a few more months.